Showing 1–12 of 28 results

Presentations [PEGS 2024] Fast-tracking Checkpoint Antibody Development with MOA-Reflective Assays for Cancer & Autoimmune Therapeutics

Checkpoint blockade antibodies are established cancer therapeutics. However, in recent years, agonistic antibodies have emerged as therapeutics not only for…

Read More
Presentations Ion Channel Drug Discovery Webinar – Recent Advances in Novel Non-opioid Pain research

In this webinar, Eurofins DiscoverX and Latigo Therapeutics come together to present recent advances in ion channel drug discovery focusing…

Read More
Presentations Advancing Therapeutics Targeting Cytokines with Functional Cell-based Assays

Jennifer Lin-Jones, Ph.D., Associate Director of Assay Development R&D Department, Eurofins DiscoverX

Read More
Presentations [PEGS 2023] Accelerating Immuno-Oncology Drug Discovery with MOA-Reflective, Functional Cell-Based Assays

Venkatesh Chari, Ph.D. Scientific Market Development Manager Eurofins DiscoverX Products LLC

Read More
Presentations [WCB 2020] Accelerate Your COVID-19 Drug Discovery with Qualified Cell-Based Assays for Proinflammatory Cytokines

Gaurav Agrawal, Ph.D. Scientific Development Manager, Eurofins DiscoverX

Read More